SO
APGE icon

STRS Ohio’s Apogee Therapeutics APGE Stock Holding History

STRS Ohio’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$370K Buy
4,400
+1,100
+33% +$79.9K ﹤0.01% 1237
2025
Q4 		$249K Buy
+3,300
New +$208K ﹤0.01% 1421
2025
Q1 		– Sell
-5,500
Closed -$249K – 1933
2024
Q4 		$249K Sell
5,500
-600
-10% -$30.6K ﹤0.01% 1430
2024
Q3 		$358K Hold
6,100
– – ﹤0.01% 1392
2024
Q2 		$240K Buy
6,100
+2,200
+56% +$107K ﹤0.01% 1513
2024
Q1 		$259K Sell
3,900
-200
-5% -$8.73K ﹤0.01% 1484
2023
Q4 		$114K Hold
4,100
– – ﹤0.01% 1674
2023
Q3 		$87K Buy
+4,100
New +$90.3K ﹤0.01% 1735

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

STRS Ohio's APGE Position: Q1 2026 in Review

STRS Ohio increased its Apogee Therapeutics (APGE) stake by 33% in Q1 2026, buying an estimated $79.9K and bringing the position to 4,400 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #1237.

STRS Ohio first reported a position in APGE in Q3 2023 and has held it in 8 quarters since. 224 funds tracked by Wall St. Rank hold APGE as of Q1 2026.

  • STRS Ohio held 4,400 shares of Apogee Therapeutics worth $370K as of Q1 2026.
  • STRS Ohio bought 1,100 Apogee Therapeutics shares in Q1 2026, an estimated $79.9K.
  • Apogee Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1237 holding.
  • STRS Ohio first reported a position in Apogee Therapeutics in Q3 2023 and has held it in 8 quarters since.
  • 224 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.